Literature DB >> 6672068

Volume of sella turcica in normals and patients with peripheral endocrinopathies or idiopathic gonadotropin deficiency.

P N Singhellakis, A C Ntailianas, C C Alevizaki, D G Ikkos.   

Abstract

The volume of sella turcica (VST) was estimated from x-ray films in i) 883 control subjects (507 men and 376 women), ii) 135 adult patients with peripheral endocrine gland insufficiences (71 of the thyroid, 15 of the adrenals and 49 of the gonads) and iii) 41 adult patients with idiopathic gonadotropin deficiency. The mean VST value of men (1356 +/- 22 mm3) was significantly lower (p less than 0.05) than that of women (1428 +/- 25 mm3). This difference resulted from a progressive increase of VST in women after the age of 45 (r = 0.254, p less than 0.001); the mean VST value of women aged less than 45 years (1301 +/- 33 mm3) been similar to that of men (p less than 0.05). VST was significantly (p less than 0.001) increased in peripheral endocrine insufficiences, this increase varying approximately between + 30% and + 55% of the mean volume of normals according to the endocrinopathy. Definitely abnormal sella turcica (VST larger than + 2SD) were observed in a percentage smaller than 27% of the cases in all groups. Furthermore, the increase in VST was significantly related to the severity of the disease in primary hypothyroidism (p less than 0.001) and the duration of the abnormal condition in Addison's disease and primary gonadal failure (p less than 0.001). Finally, VST was found within normal limits in patients with idiopathic gonadotropin deficiency. It is concluded that natural (menopause) or pathological peripheral endocrine insufficiency leads to VST enlargement which exceeds the upper normal limits in less than 27% of the cases.

Entities:  

Mesh:

Year:  1983        PMID: 6672068     DOI: 10.1007/BF03348340

Source DB:  PubMed          Journal:  J Endocrinol Invest        ISSN: 0391-4097            Impact factor:   4.256


  23 in total

1.  Spectrum of pituitary alterations with mild and severe thyroid impairment.

Authors:  S T Bigos; E C Ridgway; I A Kourides; F Maloof
Journal:  J Clin Endocrinol Metab       Date:  1978-02       Impact factor: 5.958

2.  MULTIPLE ENDOCRINE ORGAN REFRACTORINESS TO TROPHIC HORMONE STIMULATION. A PATIENT WITH AN ENLARGED SELLA TURCICA AND INCREASED FSH SECRETION.

Authors:  S J GORDON; A M MOSES
Journal:  Ann Intern Med       Date:  1965-08       Impact factor: 25.391

3.  The volume of the sella turcica.

Authors:  G DI CHIRO; K B NELSON
Journal:  Am J Roentgenol Radium Ther Nucl Med       Date:  1962-06

4.  Production of pituitary tumors in mice by chronic administration of a thiouracil derivative.

Authors:  G E MOORE; E L BRACKNEY; F G BOCK
Journal:  Proc Soc Exp Biol Med       Date:  1953-04

5.  The pituitary and primary hypothyroidism. Enlargement and unusual growth hormone secretory responses.

Authors:  A M Lawrence; J F Wilber; T C Hagen
Journal:  Arch Intern Med       Date:  1973-09

6.  Target gland insufficiency and pituitary tumours.

Authors:  S Leiba; B Landau; A Ber
Journal:  Acta Endocrinol (Copenh)       Date:  1969-01

7.  Sella turcica enlargement and primary adrenal insufficiency.

Authors:  R G Dluhy; T J Moore; G H Williams
Journal:  Ann Intern Med       Date:  1978-10       Impact factor: 25.391

8.  [Variations in the volume of the sella turcica in primary hypothyroidism and hypopituitarism].

Authors:  R Boukhris; M Sellami; H Guedri; M Ben Cheink; F Ben Khalifa; H Ben Ayed
Journal:  Nouv Presse Med       Date:  1978-01-21

9.  Probable pituitary adenoma with adrenocorticotropin hypersecretion (corticotropinoma) secondary to Addison's disease.

Authors:  A Jara-Albarran; J Bayort; A Caballero; J Portillo; L Laborda; M Sampedro; C Cure; J M Mateos
Journal:  J Clin Endocrinol Metab       Date:  1979-08       Impact factor: 5.958

10.  A pituitary tumour with possible ACTH and TSH hypersecretion in a patient with Addison's disease and primary hypothyroidism.

Authors:  S Aanderud; H H Bassøe
Journal:  Acta Endocrinol (Copenh)       Date:  1980-10
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.